These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31220436)

  • 1. Yangonin protects against estrogen-induced cholestasis in a farnesoid X receptor-dependent manner.
    Dong R; Wang J; Gao X; Wang C; Liu K; Wu J; Liu Z; Sun H; Ma X; Meng Q
    Eur J Pharmacol; 2019 Aug; 857():172461. PubMed ID: 31220436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity.
    Kong Y; Gao X; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Sun P; Meng Q
    Eur J Pharmacol; 2018 Apr; 824():64-71. PubMed ID: 29427579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yangonin modulates lipid homeostasis, ameliorates cholestasis and cellular senescence in alcoholic liver disease via activating nuclear receptor FXR.
    Kong L; Dong R; Huang K; Wang X; Wang D; Yue N; Wang C; Sun P; Gu J; Luo H; Liu K; Wu J; Sun H; Meng Q
    Phytomedicine; 2021 Sep; 90():153629. PubMed ID: 34304130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotection of auraptene from the peels of citrus fruits against 17α-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor.
    Wang J; Fu T; Dong R; Wang C; Liu K; Sun H; Huo X; Ma X; Yang X; Meng Q
    Food Funct; 2019 Jul; 10(7):3839-3850. PubMed ID: 31210195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor.
    Li T; Xu L; Zheng R; Wang X; Li L; Ji H; Hu Q
    Phytomedicine; 2020 Mar; 68():153153. PubMed ID: 32018210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.
    Meng Q; Chen XL; Wang CY; Liu Q; Sun HJ; Sun PY; Huo XK; Liu ZH; Yao JH; Liu KX
    Toxicol Appl Pharmacol; 2015 Mar; 283(3):178-86. PubMed ID: 25655198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice.
    Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Yao J; Liu K
    Pharm Res; 2015 Nov; 32(11):3688-98. PubMed ID: 26040663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatoprotection of yangonin against hepatic fibrosis in mice via farnesoid X receptor activation.
    Wang X; Fu T; Wang J; Wang C; Liu K; Wu J; Sun H; Ma X; Sun P; Meng Q
    Int Immunopharmacol; 2019 Oct; 75():105833. PubMed ID: 31450152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of AMP-activated protein kinase α1 in 17α-ethinylestradiol-induced cholestasis in rats.
    Li X; Liu R; Luo L; Yu L; Chen X; Sun L; Wang T; Hylemon PB; Zhou H; Jiang Z; Zhang L
    Arch Toxicol; 2017 Jan; 91(1):481-494. PubMed ID: 27090119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational discovery and experimental verification of farnesoid X receptor agonist auraptene to protect against cholestatic liver injury.
    Gao X; Fu T; Wang C; Ning C; Kong Y; Liu Z; Sun H; Ma X; Liu K; Meng Q
    Biochem Pharmacol; 2017 Dec; 146():127-138. PubMed ID: 28987596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.
    Li T; Zheng R; Xu L; Zhou M; Wang X; Guo Q; Ji H; Li L
    Toxicol Appl Pharmacol; 2020 Dec; 408():115248. PubMed ID: 32976922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
    Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
    Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamine attenuates obstructive cholestasis in rats via farnesoid X receptor-mediated regulation of Bsep and Mrp2.
    Liu B; Li Y; Ji H; Lu H; Li H; Shi Y
    Can J Physiol Pharmacol; 2017 Feb; 95(2):215-223. PubMed ID: 28051334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
    Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
    Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor.
    Dong R; Yang X; Wang C; Liu K; Liu Z; Ma X; Sun H; Huo X; Fu T; Meng Q
    Phytomedicine; 2019 Feb; 53():134-142. PubMed ID: 30668392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis.
    Fiorucci S; Clerici C; Antonelli E; Orlandi S; Goodwin B; Sadeghpour BM; Sabatino G; Russo G; Castellani D; Willson TM; Pruzanski M; Pellicciari R; Morelli A
    J Pharmacol Exp Ther; 2005 May; 313(2):604-12. PubMed ID: 15644430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholestasis-induced bile acid elevates estrogen level via farnesoid X receptor-mediated suppression of the estrogen sulfotransferase SULT1E1.
    Liu X; Xue R; Yang C; Gu J; Chen S; Zhang S
    J Biol Chem; 2018 Aug; 293(33):12759-12769. PubMed ID: 29929982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo.
    Yang F; Wang Y; Li G; Xue J; Chen ZL; Jin F; Luo L; Zhou X; Ma Q; Cai X; Li HR; Zhao L
    Br J Pharmacol; 2018 Mar; 175(5):810-829. PubMed ID: 29235094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Farnesoid X Receptor: Effective alleviation of rifampicin -induced liver injury.
    Zhou Y; Li M; Cao Y; Chang W; Jia H; Wang L; Xu H; Wang Y; Liu P; Chen WD
    Int Immunopharmacol; 2024 Sep; 139():112799. PubMed ID: 39068755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.